Table 1.
Baseline characteristics of the 10 AF patients analysed
| Baseline characteristic | Total (n = 10) |
|---|---|
| Male | 7 (70%) |
| Age (years) | 71 ± 9 |
| BMI (kg/m2) | 29 ± 4 |
| History | |
| Hypertension | 5 (50%) |
| Diabetes mellitus | 2 (20%) |
| Coronary artery disease | 7 (70%) |
| PCI | 7 (70%) |
| CABG | 0 (0%) |
| Cerebrovascular accident | 1 (10%) |
| TIA | 1 (10%) |
| Medication | |
| Betablocker | 7 (70%) |
| Verapamil/diltiazem | 0 (0%) |
| Anti-coagulants | 10 (100%) |
| NOAC | 7 (70%) |
| Acenocoumarol | 3 (30%) |
| Echocardiography | |
| Left atrial volume (mL) | 120 (101–131) |
| Left atrial volume index (mL/m2) | 60 (50–77) |
| LVEDD (mm) | 54 ± 8 |
| IVSD (mm) | 10 ± 1 |
| PWD (mm) | 9 ± 1 |
| LVEF (%) (Teichholtz method) | 44 (38–62) |
| Septal E/e′ | 9.0 ± 3.1 |
| Lateral E/e′ | 7.1 ± 2.4 |
BMI, body mass index; CABG, coronary artery bypass grafting; IVSD, interventricular septum diameter during diastole; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; NOAC, non-vitamin-K-antagonist oral anti-coagulant; PCI, percutaneous coronary intervention; PWD, posterior wall diameter during diastole; TIA, transient ischaemic attack.